These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36190235)

  • 1. Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma.
    Karbhari N; Barney R; Palisoul S; Hong J; Lin CC; Zanazzi G
    J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research.
    Beechem JM
    Methods Mol Biol; 2020; 2055():563-583. PubMed ID: 31502169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Multiplexed Spatially Resolved Proteomic and Transcriptional Profiling of the Glioblastoma Microenvironment Using Archived Formalin-Fixed Paraffin-Embedded Specimens.
    Kim Y; Danaher P; Cimino PJ; Hurth K; Warren S; Glod J; Beechem JM; Zada G; McEachron TA
    Mod Pathol; 2023 Jan; 36(1):100034. PubMed ID: 36788070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A user's perspective on GeoMx
    Van TM; Blank CU
    Immunooncol Technol; 2019 Jul; 1():11-18. PubMed ID: 35755324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex digital spatial profiling of proteins and RNA in fixed tissue.
    Merritt CR; Ong GT; Church SE; Barker K; Danaher P; Geiss G; Hoang M; Jung J; Liang Y; McKay-Fleisch J; Nguyen K; Norgaard Z; Sorg K; Sprague I; Warren C; Warren S; Webster PJ; Zhou Z; Zollinger DR; Dunaway DL; Mills GB; Beechem JM
    Nat Biotechnol; 2020 May; 38(5):586-599. PubMed ID: 32393914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Molecular Characterization Using Digital Spatial Profiling Technology on Immunooncology Targets in Methylated Compared with Unmethylated IDH-Wildtype Glioblastoma.
    Barber H; Tofias A; Lander B; Daniels A; Gong J; Ren Y; Ren X; Liang Y; White P; Kurian KM
    J Oncol; 2021; 2021():8819702. PubMed ID: 33995529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions.
    Buehler M; Yi X; Ge W; Blattmann P; Rushing E; Reifenberger G; Felsberg J; Yeh C; Corn JE; Regli L; Zhang J; Cloos A; Ravi VM; Wiestler B; Heiland DH; Aebersold R; Weller M; Guo T; Weiss T
    Neuro Oncol; 2023 Feb; 25(2):290-302. PubMed ID: 35802605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
    Dejaegher J; Verschuere T; Vercalsteren E; Boon L; Cremer J; Sciot R; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2017 Nov; 141(9):1891-1900. PubMed ID: 28681455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma.
    Lin GL; Nagaraja S; Filbin MG; Suvà ML; Vogel H; Monje M
    Acta Neuropathol Commun; 2018 Jun; 6(1):51. PubMed ID: 29954445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era.
    Larkin CJ; Arrieta VA; Najem H; Li G; Zhang P; Miska J; Chen P; James CD; Sonabend AM; Heimberger AB
    Front Immunol; 2022; 13():907605. PubMed ID: 35784281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins.
    Ross JL; Cooper LAD; Kong J; Gutman D; Williams M; Tucker-Burden C; McCrary MR; Bouras A; Kaluzova M; Dunn WD; Duong D; Hadjipanayis CG; Brat DJ
    Sci Rep; 2017 Nov; 7(1):15593. PubMed ID: 29142297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Features of the Tumor Immune Microenvironment in Glioma and Their Clinical Applications: Analysis of Multiple Cohorts.
    Zhang C; Zhang Y; Tan G; Mi W; Zhong X; Zhang Y; Zhao Z; Li F; Xu Y; Zhang Y
    Front Immunol; 2022; 13():853074. PubMed ID: 35677045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioma pathophysiology: insights emerging from proteomics.
    Deighton RF; McGregor R; Kemp J; McCulloch J; Whittle IR
    Brain Pathol; 2010 Jul; 20(4):691-703. PubMed ID: 20175778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the Brain Microenvironment in Diffusely Infiltrating Low-Grade Glioma.
    Torres D; Canoll P
    Neurosurg Clin N Am; 2019 Jan; 30(1):27-34. PubMed ID: 30470402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Profiling of the Tumor Microenvironment.
    Capello M; Katayama H; Hanash SM
    Methods Mol Biol; 2022; 2435():157-167. PubMed ID: 34993945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement.
    Widhalm G; Wolfsberger S; Minchev G; Woehrer A; Krssak M; Czech T; Prayer D; Asenbaum S; Hainfellner JA; Knosp E
    Cancer; 2010 Mar; 116(6):1545-52. PubMed ID: 20108311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx
    Bergholtz H; Carter JM; Cesano A; Cheang MCU; Church SE; Divakar P; Fuhrman CA; Goel S; Gong J; Guerriero JL; Hoang ML; Hwang ES; Kuasne H; Lee J; Liang Y; Mittendorf EA; Perez J; Prat A; Pusztai L; Reeves JW; Riazalhosseini Y; Richer JK; Sahin Ö; Sato H; Schlam I; Sørlie T; Stover DG; Swain SM; Swarbrick A; Thompson EA; Tolaney SM; Warren SE; On Behalf Of The GeoMx Breast Cancer Consortium
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor immune microenvironment of primary and metastatic HER2- positive breast cancers utilizing gene expression and spatial proteomic profiling.
    Schlam I; Church SE; Hether TD; Chaldekas K; Hudson BM; White AM; Maisonet E; Harris BT; Swain SM
    J Transl Med; 2021 Nov; 19(1):480. PubMed ID: 34838031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.